Skip to main content
JHS Svendgaard Laboratories Ltd. logo

JHS Svendgaard Laboratories Ltd. — Investor Relations & Filings

Ticker · JHS ISIN · INE544H01014 LEI · 335800NYNAOOMRTTWW75 BSE.NS Manufacturing
Open in API
Filings indexed 678 across all filing types
Latest filing 2023-12-28 Regulatory Filings
Country IN India
Listing BSE.NS JHS

About JHS Svendgaard Laboratories Ltd.

https://www.svendgaard.com/

JHS Svendgaard Laboratories Ltd. is a specialized manufacturer of oral care products, operating primarily through contract manufacturing and private labeling arrangements. The company provides end-to-end solutions for oral hygiene, including the production of toothbrushes, toothpastes, mouthwashes, and specialized dental care items. It maintains large-scale manufacturing facilities equipped to handle high-volume production for global and domestic FMCG brands. In addition to its business-to-business operations, the company manages its own consumer brand, Aquawhite, which focuses on innovative oral care solutions for various age groups, including a significant range of licensed character-based products for children. The organization emphasizes quality control and technical expertise in oral health product development, catering to diverse market segments through a robust supply chain and distribution network.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the closure of the trading window for insiders ahead of the announcement of quarterly financial results. It does not contain any financial data or detailed report content. It is an announcement related to compliance and insider trading regulations, not a financial report or earnings release itself. The document length is only 1455 characters, indicating it is a brief notice. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-12-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of a conference call held on November 8, 2023, discussing the quarterly and half-year financial results for the period ended September 30, 2023. It includes detailed management commentary, financial performance figures, strategic updates, and a Q&A session with investors and analysts. The presence of a moderator, management speakers, and Q&A confirms it is a full transcript of an earnings call. The document is about 15,000 characters long, indicating it is a full transcript rather than a brief announcement or summary. Therefore, the document fits the definition of a Call Transcript (CT).
2023-11-10 English
Copy of Newspaper Publication
Regulatory Filings
2023-11-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short communication addressed to stock exchanges regarding the availability of the audio recording of a conference call discussing the company's un-audited financial results for the quarter and half year ended September 30, 2023. It references a prior intimation about the conference call and provides a link to the audio recording on the company's website. The document does not contain the transcript itself, financial data, or detailed analysis, but merely informs about the availability of the conference call audio. According to the classification rules, such a document is best classified as a Regulatory Filing (RNS) because it is an announcement related to a conference call audio availability and does not contain the full transcript or substantive financial content. The document length is short (1515 characters), supporting that it is an announcement rather than a full report or transcript.
2023-11-08 English
Investor Presentation
Interim / Quarterly Report Classification · 100% confidence The document is dated November 8, 2023, and references a conference call for analysts and investors discussing the un-audited financial results for the quarter and half year ended September 30, 2023. It includes detailed consolidated financial highlights for Q2 FY24 and H1 FY24, with extensive financial data such as revenue, expenses, EBITDA, PBT, PAT, and EPS. The document also contains an investor presentation with company overview, recent developments including a scheme of amalgamation, managing director's message, and detailed financial tables and charts. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year (quarter and half year) indicates this is an Interim / Quarterly Report. The document is lengthy (15,000 characters) and contains substantive financial data, not merely an announcement or a certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2023-11-08 English
Financial Result Updates
Regulatory Filings
2023-11-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.